NCT00011375View on ClinicalTrials.gov

Rolipram to Treat Multiple Sclerosis

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

February 28, 2001

Study Completion Date

April 30, 2004

Conditions
Multiple Sclerosis
Interventions
DRUG

Rolipram

Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00011375 - Rolipram to Treat Multiple Sclerosis | Biotech Hunter | Biotech Hunter